1. No category

March 31-April 2, 2015
Shangri-La Pudong Hotel – Shanghai, China
“Healthcare ROI by 2020: Betting on China or US?”
DRAFT PROGRAM AGENDA & SCHEDULE OF EVENTS
DAY ONE: TUESDAY, MARCH 31, 2015
12:30 p.m. – 4:30 p.m.
Pre-Conference & Boot Camp Registration
ENTREPRENEUR BOOT CAMP
1:00 pm – 1:05 pm
Opening Remarks
Karen Wong, Partner, Wilson Sonsini Goodrich & Rosati (confirmed)
Kewen Jin, Chairman, BayHelix (confirmed)
1:00 pm – 2:00 pm
Creatively Seeking Funding Sources for Your Diagnostic, Drug, Medical
Device and E-health Companies
Moderator:
Karen Wong, Partner, Wilson Sonsini Goodrich & Rosati (confirmed)
Sabrina Li, CEO, Coyote Biosciences (confirmed)
Peter Luo, CEO, Adagene (confirmed)
2:00 pm – 2:30 pm
“IP Strategy” - Getting Ready for Funding Pitch and Beyond
Moderator: Yuwen Liu, Executive Director, BioBAY (confirmed)
Karen Wong, Partner, Wilson Sonsini Goodrich & Rosati (confirmed)
SIPO (invited)
Kang Ying, CEO, AccuraGen (confirmed)
Alex Chen, CEO, CrystalTech (confirmed)
2:30 pm – 2:45 pm
Coffee Break
2:45 pm – 3:45 pm
Current Market Conditions for IPO and What Are the Challenges in
Investment Exit Through Capital Markets
Moderator: Ethan Jin, Partner, Wilson Sonsini Goodrich & Rosati
(confirmed)
Jianqiu Ge, Managing Director, GLB Capital (confirmed)
Liwei Jiang, CEO, PW Meditech Group (invited)
3:45 pm – 4:00 pm
Q&A
4:00 pm – 5:30 pm
Emerging Company Showcase
Moderator: Kewen Jin, Chairman, BayHelix (confirmed)
Peng Wang, GM, Yabao Pharmaceuticals (confirmed)
Marietta Wu, COO, Zai Laboratory (confirmed)
Jun Bao, SVP & Chief Business Officer, Shenogen (confirmed)
Nick Zhang, GM, QIAGEN Translational Medicine (confirmed)
Shu Jen Chen, CSO, ACT Genomics (confirmed)
Tsang-Bing Tzeng, CEO, TAP (confirmed)
5:30 pm – 7:00 pm
WSGR BayHelix Welcome Cocktail Reception
DAY TWO: WEDNESDAY, APRIL 1, 2015
7:15 am – 8:15 am
Registration
8:00 am – 8:15 am
Introductory Remarks
8:15 am – 8:45 am
Technology Innovation and Global Collaboration in China
Pharmaceutical Industry
Guowei Sang, Ex-Vice Chairman of Standing Committee of National
People’s Congress (invited)
8:45 am – 9:15 am
Current Development status and challenges in China Pharmaceutical
Industry
Hongren Zhu, Chief Engineer, Ministry of Industry and Information
Technology (invited)
9:15 am – 9:45 am
Supervisory Policy and Development Status of China’s Biosimilar
Maozhong Li, vice Director, Dept. of Drug and Cosmetics Registration,
SFDA (invited)
9:45 am – 10:15 am
The Strategic Positioning for Chinese Companies in the Global Market
Dianbo Liu, Executive Chairman, Luye Pharmaceutical (confirmed)
10:15 am – 10:45 am
How Chinese Companies Can Face the World
Tsu Der Lee, Chairman, SwissRay (confirmed)
10:45 am – 11:15 am
The Paradigm Shift of China Healthcare Market Value Chain
Richard Yeh, Head of China Healthcare Equity Research, Citi (confirmed)
11:15 am – 12:15 pm
Panel Discussion: Innovation in China
Ruilin Song, Chairman, SINO PHIRDA (confirmed)
Chinese Academy of Sciences (invited)
Samantha Du, CEO, Zai Laboratory (confirmed)
Steve Yang, EVP & COO, WuXi AppTec (confirmed)
12:15 pm – 1:30 pm
Lunch & Networking
TRACK ONE: PHARMACEUTICALS & BIOTECH
Session Chairs:
Jasmine Luo, VP & CIO, China Health Industry Capital Fund Management
(confirmed)
Marietta Wu, COO, Zai Laboratory (confirmed)
1:30 pm – 2:00 pm
The State of US Biotech
David Flores, CEO, BioCentury (confirmed)
2:00 pm – 3:00 pm
Panel Discussion: Biosimilar and Biologics Drug Development in China
Aradhana Sarin, Managing Director, Global Healthcare, Citi (confirmed)
Chris Chen, SVP & CTO, Biologics Services, WuXi AppTec (confirmed)
Michael Yu, President & CEO, Innovent Biologics (confirmed)
Zhenping Zhu, EVP, Biologics & President, Kadmon China (confirmed)
Daotian Fu, General Manager, Livzon Mabpharm (confirmed)
3:00 pm – 6:00 pm
Company Presentations & Discussion
Yunshu Zhou, GM, Jiangsu Hengrui Pharmaceuticals (confirmed)
Sino Biopharm (invited)
Yinxiang Wang, CEO, Betta Pharmaceuticals (invited)
Friedhelm Blobel, CEO, SciClone Pharmaceuticals (confirmed)
Wren Zhang, CEO & President, GC-Rise (confirmed)
Michael Yu, President & CEO, Innovent Biologics (confirmed)
John Oyler, CEO, Beigene (confirmed)
Ting Xu, CEO & President, Alphamab (confirmed)
Racho Jordanov, President & CEO, JHL Biotech (confirmed)
6:00 pm – 6:15 pm
Closing Remarks
6:15 pm – 7:00 pm
Cocktail Reception
7:00 pm – 8:30 pm
Conference Gala Dinner Hosted by Citi
TRACK TWO: HEALTHCARE SERVICES
Session Chair:
Norman Chen, Venture Partner, Fidelity Growth Partners Asia (confirmed)
1:30 pm – 2:00 pm
Opportunities and Challenges of Operating Private Hospitals in Asia
See Leng Tan, Managind Director & CEO, IHH Healthcare Berhad
(confirmed)
2:00 pm – 5:15 pm
Company Presentations & Discussion
Adam Sun, Concord (confirmed)
United Family (invited)
Tim Guo, Delta Health (invited)
Phoenix (invited)
Jacqueline Mei, Fosun (confirmed)
Shijun Wu, Aier Ophthalmology (confirmed)
5:15 pm – 6:00 pm
Panel Discussion: Private Hospitals in China- More Risks or More
Rewards?
Moderator:
Norman Chen, Venture Partner, Fidelity Growth Partners Asia (confirmed)
Panelists:
Jiadi Yu, Senior Investment Officer, IFC (confirmed)
Concord (confirmed)
Fosun (confirmed)
Shijun Wu, Aier Ophthalmology (confirmed)
6:00 pm – 6:15 pm
Closing Remarks
6:15 pm – 7:00 pm
Cocktail Reception
7:00 pm – 8:30 pm
Conference Gala Dinner Hosted by Citi
DAY THREE: THURSDAY, APRIL 2, 2015
7:45 am – 8:15 am
Registration
8:15 am – 8:30 am
Introductory Remarks
8:30 am – 9:00 am
Medical Associations - A Catalyst for Change
Henry Solomon, Senior Medical Advisor & Chair, Professional and
Corporate Consortium, American College of Cardiology (confirmed)
9:00 am – 9:30 am
The Strategic Positioning and Roadmap for Chinese Market for
Multinational Company
Vladimir Makatsaria, Company Group Chairman, JNJ Asia (confirmed)
9:30 am – 10:30 am
Panel Discussion: MNC’s vs Local Companies: The Dynamic of
Competition in China
Moderator: Chen Yu, Managing Partner, Vivo Capital (confirmed)
Libo Yang, JRB (confirmed)
Jay Qin, Chairman, Shanghai Kinetic (confirmed)
Noam Krantz, Vice President, Johnson & Johnson (confirmed)
Lifei Cheng, Senior Director, Business Development & Strategy Medtronic
(confirmed)
Tsu Der Lee, Chairman, SwissRay (confirmed)
10:30 am – 12:00 pm
Panel Discussion: Private Equity Investment: What’s HOT in China?
Moderator: Frank Kung, Managing Partner, Vivo Capital (confirmed)
Jonathan Wang, Senior Managing Director, OrbiMed (confirmed)
Rebecca Lin, Partner, Fidelity (invited)
Jasmine Luo, VP & CIO, China Health Industry Capital Fund Management
(confirmed)
James Hsu, Senior Vice President, CDIB (invited)
Dong Liu, Managing Director, CITICPE (confirmed)
12:00 pm – 1:15 pm
Lunch and Networking
TRACK THREE: MEDTECH (DEVICES, INSTRUMENTS, DIAGNOSTICS)
Session Chair:
Chen Yu, Managing Partner, Partner, Vivo Capital (confirmed)
1:30 pm – 2:00 pm
A Multinational’s China Strategy
Christopher Cleary, VP, Corporate Development, Medtronic (confirmed)
2:00 pm – 4:30 pm
Company Presentations & Discussion
Victor Chao, GM, Golden Stapler Surgical (confirmed)
Mike Zhu, Executive VP, Amoy Diagnostics (confirmed)
Jianqing Yao, CEO, Shanghai Ketai Medical Device (confirmed)
Guanghui Hu, President, Admera (confirmed)
Jay Qin, Chairman, Shanghai Kinetic (confirmed)
Hong Tan, CEO, ET Healthcare (confirmed)
Pan Zheng, CEO, MicroTech Medical (confirmed)
Vivi Long, GM, Apex Medical (confirmed)
Yihua Ning, SceneRay (confirmed)
4:30 pm – 5:30 pm
NGS: How Could Genomics Change the Landscape of Disease
Prevention and Treatment?
David Wang, Senior Managing Director, OrbiMed (confirmed)
Edward Hu, CIO, CFO, WuXi AppTec (confirmed)
Victor Shi, President, Asia-Pacific, QIAGEN (confirmed)
5:30 pm
Conference Concludes
5:30 pm – 8:00 pm
Innovation Night at Boston Scientific Innovation Center
TRACK FOUR: EHEALTHCARE
Session Chairs:
James Li, VP & GM, Greater China, Amgen (confirmed)
Cyber Cao, Principal, Vivo Capital (confirmed)
1:30 pm – 2:00 pm
An Overview of US eHealth Market Dynamics and Business Models
Steven Yecies, Venture Partner, OrbiMed (confirmed)
2:00 pm – 2:30 pm
Emerging Force of Chinese eHealth
Frank Le Deu, Partner, McKinsey & Co. (confirmed)
2:30 pm – 4:30 pm
Company Presentations and Discussion
Li Ma, VP of Strategy, AliHealth (confirmed)
Rui Zhang, CEO, Spring Rain (confirmed)
Junhai Wang, Co-Founder, Zhang Shang Yao Dian (confirmed)
Bo Liu, CEO, Huakang Mobile Health (confirmed)
CEO/Chairman, J1.com (confirmed)
Guanjing Zhang, Chairman, E-Techco (confirmed)
Yanxiong Wang, Founder, 360kad.com (confirmed)
Weining Software (invited)
4:30 pm – 5:30 pm
Panel Discussion: Healthcare IT/mHealth
Steven Yecies, Venture Partner, OrbiMed US (confirmed)
Li Ma, VP of Strategy, AliHealth (confirmed)
Wenxin Yu, Pharmaceutical Researcher, Haitong Securities (confirmed)
Jiang Zhang, GM, PingAn Ventures (confirmed)
Yiqin Yin, Head of IT, Zhongshan Hospital (confirmed)
5:30 pm
Conference Concludes
5:30 pm – 8:00 pm
Innovation Night at Boston Scientific Innovation Center